Characterisation of Molecular Events Following Cisplatin Treatment of Two Curable Ovarian Cancer Models: Contrasting Role for P53 Induction and Apoptosis in Vivo

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6602167
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Induction of DISE in Ovarian Cancer Cells in Vivo

Oncotarget
Oncology
2017English

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

The Role of Free Radicals and P53 in Neuron Apoptosis in Vivo

Journal of Neuroscience
Neuroscience
1995English

Co-Expression of ING4 and P53 Enhances Hypopharyngeal Cancer Chemosensitivity to Cisplatin in Vivo

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Minicapsules Encapsulating Nanoparticles for Targeting, Apoptosis Induction and Treatment of Colon Cancer

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Mifepristone Abrogates Repopulation of Ovarian Cancer Cells in Between Courses of Cisplatin Treatment

International Journal of Oncology
Cancer ResearchOncology
2009English

Upregulation of Acetylcholinesterase Mediated by P53 Contributes to Cisplatin-Induced Apoptosis in Human Breast Cancer Cell

Journal of Cancer
Oncology
2015English

P53 Reactivation With Induction of Massive Apoptosis-1 (PRIMA-1) Inhibits Amyloid Aggregation of Mutant P53 in Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy